// App-Quantinova.ai

2199 : Primary Non-adherence to Biologics and Immunomodulatory Therapies for Rheumatoid Arthritis, Psoriatic Arthritis, and Spondyloarthritis Using Linked EHR and Pharmacy Claims Data

Researchers

Presenter

  • Jeffrey Curtis

Principal Investigators

  • Yujie Su

  • Cassie Clinton

  • Patrick Stewart

  • Bryant England

  • Tim Buekelman

  • Fenglong Xie

Medical Centers

  • Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL

  • University of Alabama at Birmingham, Birmingham, AL

  • Bendcare, Boca Raton, FL

  • University of Nebraska Medical Center, Omaha, NE

  • FASTER, Hoover, AL

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Dermatology

  • Musculoskeletal

Disease

  • Axial spondyloarthritis

  • Rheumatoid arthritis

  • Psoriatic arthritis

  • Spondyloarthritis

  • Psoriasis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved